PPI Versus Placebo in Severe Functional Heartburn
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00222989 |
Recruitment Status
:
Withdrawn
(Study never started.)
First Posted
: September 22, 2005
Last Update Posted
: April 14, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
GERD | Drug: PPI | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Intervention Model: | Single Group Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | PPI Versus Placebo in Severe Functional Heartburn |
Study Start Date : | October 2003 |
Estimated Primary Completion Date : | December 1, 2100 |
Estimated Study Completion Date : | December 1, 2100 |

Arm | Intervention/treatment |
---|---|
no label study
1
|
Drug: PPI |
- Difference in GERD controll PPI vs Placebo based on a validated GERD questionnarir. [ Time Frame: 1 year ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 100 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Heartburn twice a week for at least 2 years. Normal EGD and 24hr pH study.
Exclusion Criteria:
- <18yrs of age,pregnant, unable or unwilling to give consent, allergic to PPI, previous gastric or esophageal surgery, past hx of erosive GERD, unwilling or unable to stop acid suppression meds

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00222989
United States, California | |
USC Keck School of Medicine | |
LA, California, United States, 90033 |
Principal Investigator: | Michael M Kline, MD | University of Southern California |
Responsible Party: | Michael M Kline, Associate Professor of Clinical Medicine, University of Southern California |
ClinicalTrials.gov Identifier: | NCT00222989 History of Changes |
Other Study ID Numbers: |
#026020 474200 |
First Posted: | September 22, 2005 Key Record Dates |
Last Update Posted: | April 14, 2017 |
Last Verified: | April 2017 |
Keywords provided by Michael M Kline, University of Southern California:
GERD PPI Functional heartburn |
Additional relevant MeSH terms:
Heartburn Signs and Symptoms, Digestive Signs and Symptoms |